Investigation of Subclinical Cardiotoxicity in Chronic Leukemia Patients with Non-invasive Tests

Investigation of Subclinical Cardiotoxicity in Chronic Leukemia Patients with Non-invasive Tests

Introduction:This study aimed to investigate the left ventricular function and electrocardiographic findings in patients with chronic leukemia receiving and not receiving chemotherapy during a one-year follow-up.Methods:A total of 111 patients with chronic leukemia were included in the study. Electr...

Full description

Bibliographic Details
Main Authors:	Timor Omar, Rasim Enar, Barış İkitimur, Burçak Kılıçkıran Avcı
Format:	Article
Language:	English
Published:	Galenos Yayinevi 2019-11-01
Series:	İstanbul Medical Journal
Subjects:	chronic leukemia heart failure cardiotoxicity
Online Access:	http://imj.galenos.com.tr/archives/archive-detail/article-preview/nvestigation-of-subclinical-cardiotoxicity-in-chro/31949

Similar Items

Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer
by: Maria C. Arciniegas Calle, et al.
Published: (2018-10-01)

Metabolomic Perspectives in Antiblastic Cardiotoxicity and Cardioprotection
by: Martino Deidda, et al.
Published: (2019-10-01)

Cardiotoxicity Associated with Anti-CD19 Chimeric Antigen Receptor T-cell (CAR-T) Therapy: Recognition, Risk Factors, and Management
by: Ethan A. Burns, et al.
Published: (2021-03-01)

Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer
by: Ariane V.S. Macedo, MD, MSc, et al.
Published: (2019-09-01)

Dexrazoxane for cardioprotection in older adults with acute myeloid leukemia
by: Pankit Vachhani, et al.
Published: (2017-01-01)

Nuclear imaging of chemotherapy-induced cardiotoxicity
by: A. A. Ansheles, et al.
Published: (2021-03-01)

Cardio-Oncology and the Intersection of Cancer and Cardiotoxicity
by: Richard K. Cheng, MD, MSc, et al.
Published: (2019-12-01)

Cardiooncology. Basic principles of prevention and treatment of cardiotoxicity in cancer patients
by: Ekaterina V. Plokhova, et al.
Published: (2019-04-01)

Cardiotoxicity of cancer therapeutics: current issues in screening, prevention and therapy
by: Richard Joseph Sheppard, et al.
Published: (2013-03-01)

Cardioprotective Roles of β-Hydroxybutyrate Against Doxorubicin Induced Cardiotoxicity
by: Yihai Liu, et al.
Published: (2021-04-01)

Anthracycline-associated cardiotoxicity in adults: systematic review on the cardioprotective role of beta-blockers
by: Roberto Ramos Barbosa, et al.

MODERN VIEW ON CARDIOTOXICITY OF CHEMOTHERAPEUTICS IN ONCOLOGY INCLUDING ANTHRACYCLINES
by: G. E. Gendlin, et al.
Published: (2017-03-01)

Cardiotoxicity - the first cause of morbidity and mortality in pediatric patients survivors of acute lymphoblastic leukemia
by: Radu Letitia Elena, et al.
Published: (2020-04-01)

Chronic exposure to arsenic and high fat diet additively induced cardiotoxicity in male mice
by: Akram Ahangarpour, et al.
Published: (2018-01-01)

Anthracycline induced cardiotoxicity: biomarkers and “Omics” technology in the era of patient specific care
by: Shayan Moazeni, et al.
Published: (2017-05-01)

Molecular Mechanisms of Cardiotoxicity Induced by ErbB Receptor Inhibitor Cancer Therapeutics
by: Gilles W. De Keulenaer, et al.
Published: (2012-09-01)

Carfilzomib induced cardiotoxicity in a multiple myeloma patient
by: Arnold Méndez-Toro, et al.
Published: (2020-09-01)

Examining Cardiotoxicity With HER2 Therapies∗
by: Neelima Denduluri, MD
Published: (2020-06-01)

Symptomatic Heart Failure in Acute Leukemia Patients Treated With Anthracyclines
by: Yu Kang, MD, PhD, et al.
Published: (2019-12-01)

Change of concentration of biochemical markers of dysfunction of endothelium at intake of inhibitors of tyrosinekinase of I and II generations at patients with a chronic myeloid leukemia as risk factor of development of cardiovascular complications
by: K. V. Naumova, et al.
Published: (2021-01-01)

Partially reversible bortezomib-induced cardiotoxicity: an unusual cause of acute cardiomyopathy
by: Marcelle G. Meseeha, et al.
Published: (2015-12-01)

Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications
by: Agata Bikiewicz, et al.
Published: (2021-08-01)

The cost-effectiveness of cardiac monitoring in breast cancer patients who have received cardiotoxic therapies
by: Mann, Teresa A.
Published: (2012)

Efficacy of Neurohormonal Therapies in Preventing Cardiotoxicity in Patients With Cancer Undergoing Chemotherapy
by: Muthiah Vaduganathan, MD, MPH, et al.
Published: (2019-09-01)

Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction
by: Maria Isabel Camara Planek, et al.
Published: (2020-07-01)

Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy
by: Anthony F. Yu, MD, et al.
Published: (2020-06-01)

Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid Tumor
by: Hui-Min Hu, et al.
Published: (2018-01-01)

Cardiovascular Toxicity of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia
by: IL Davydkin, et al.
Published: (2018-10-01)

Cardiotoxicity of tyrosine kinase inhibitors in chronic myelogenous leukemia therapy
by: Zhenshu Xu, et al.
Published: (2009-03-01)

Cardioncological Approach for Trastuzumab Therapy in Breast Cancer Patients With Cardiotoxicity: Impact on Adherence and Clinical Outcome
by: Iacopo Fabiani, et al.
Published: (2020-08-01)

Myocardial contractility dysfunction in patients with chronic lymphocytic leukemia receiving chemotherapy and their treatment with enalapril
by: I. L. Davydkin, et al.
Published: (2020-03-01)

Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: a case report
by: Santino Minichillo, et al.
Published: (2017-11-01)

Recent advances in cardio‐oncology: a report from the ‘Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019’
by: Markus S. Anker, et al.
Published: (2019-12-01)

Cardiotoxicity Complication of Radiotherapy
by: Beta Agustia Wisman, et al.
Published: (2017-12-01)

Carbamazepine Cardiotoxicity
by: J Gordon Millichap
Published: (1993-10-01)

Chloroquine Cardiotoxicity Leading to Cardiogenic Shock
by: Madeleine Alder, MD, et al.
Published: (2020-12-01)

A Similar Metabolic Profile Between the Failing Myocardium and Tumor Could Provide Alternative Therapeutic Targets in Chemotherapy-Induced Cardiotoxicity
by: Bruno Saleme, et al.
Published: (2018-06-01)

Dexrazoxane in anthracycline cardiotoxicity
by: Abhijit S Nair
Published: (2017-01-01)

Is it possible to prevent chemotherapy-induced heart failure with cardiovascular drugs - the review of the current clinical evidence
by: Korzeniowska K, et al.
Published: (2019-09-01)

Cardio-oncology: Concepts and practice
by: Richard M. Cubbon, et al.
Published: (2016-04-01)